Supplementary Protection Certificates: Where Are We and Where Are We Headed?
In this webinar, we discuss the following topics:
- An overview of the SPC landscape
- Recent issues considered by the Court of Justice of the European Union
- What does "protected by the basic patent in force" mean in the context of functional and Markush claims?
- What is the definition of "product"?
- What does "the marketing authorisation is the first authorisation to place the product on the market as a medicinal product mean" in the context of second or further medical use claims?
- The SPC waiver
- SPCs after Brexit completion date